# Eikon Therapeutics (EIKN): value investors who own it

1 value investor held Eikon Therapeutics in their Q3 2026 13F, led by Polen Capital Management.

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| Polen Capital Management | 0.0% | $466k | New | 1 |

## Directors buying and selling (Form 4, last 12 months)

| Date | Who | Role | Bought or sold | Shares | Value |
| --- | --- | --- | --- | --- | --- |
| 2026-09-03 | Column Group IV GP, LP | 10% owner | Bought | 89200 | $1.0m |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/eikn). Values traded and returns are estimates. Not investment advice. Built 2026-10-21.